David Habart

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

Alberto Tosetto, Francesco Rodeghiero, Giancarlo Castaman et al. · Journal of Thrombosis and Haemostasis · 2006 · 527 citations · Full text

Medicine, Hematology, Pathology +16

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Anne Goodeve, Jeroen Eikenboom, Giancarlo Castaman et al. · Blood · 2006 · 400 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

Giancarlo Castaman, Stefan Lethagen, Augusto B. Federici et al. · Blood · 2008 · 203 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)

Sandra L. Haberichter, Giancarlo Castaman, Ulrich Budde et al. · Blood · 2008 · 170 citations · Full text

Medicine, Molecular Medicine, Pathology +13

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)

Ulrich Budde, Reinhard Schneppenheim, Jeroen Eikenboom et al. · Journal of Thrombosis and Haemostasis · 2008 · 159 citations · Full text

Medicine, Molecular Medicine, Pathology +14